
The International mRNA Health Conference (Conference Days, 8-10 November 2022) is the premier meeting destination for industry and academic professionals to explore the rapidly advancing science and business of mRNA medicines. The first emergency use authorizations of mRNA-based vaccines in 2020, followed by full approvals in 2021 and 2022.